相关实验视频
Updated: May 12, 2025

00:07
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
7.2K
通过调节miR-146a-5p/SMAD4轴,METTL3促进口腔状细胞癌
Jayasree Peroth Jayaprakash1, Pragati Karemore1, Piyush Khandelia1
1Laboratory of Molecular Medicine, Department of Biological Sciences, Birla Institute of Technology and Science, Pilani - Hyderabad Campus, Hyderabad 500078, India.
Oncotarget
|May 8, 2025
概括
N6-甲基氨酸 (m6A) 修饰调节了口腔癌中的基因表达. METTL3酶控制miR-146a-5p,影响瘤抑制剂SMAD4,揭示了口腔状细胞癌 (OSCC) 的新治疗标.
科学领域:
- 对于RNA的表观遗传学
- 癌症生物学 癌症生物学
- 分子瘤学分子瘤学
背景情况:
- N6-甲基氨酸 (m6A) 是一种关键的RNA修饰,可以调节癌症中的基因表达.
- 主要的m6A甲基转移酶METTL3在口腔状细胞癌 (OSCC) 中被上调,影响瘤特异性表皮转录组网络.
- METTL3调节miRNA生物发生,影响与癌症相关的途径.
研究的目的:
- 调查METTL3介导的m6A修饰在OSCC中的作用.
- 在OSCC中识别由METTL3调节的特定miRNA.
- 阐明OSCC中涉及METTL3,miRNA和下游目标的监管轴.
主要方法:
- 在OSCC细胞中分析METTL3表达和全球m6A水平.
- 研究METTL3对miRNA生物发生和初级miRNA处理的影响.
- 使用分子和细胞分析识别和功能验证METTL3调节的miRNA及其标.
- 通过miR-146a-5p对SMAD4在OSCC中的作用及其监管的评估.
- 检查METTL3对SMAD4依赖信号通路的影响.
主要成果:
- 在OSCC中对METTL3进行了上调,并增加了全球m6A水平.
- METTL3积极调节miR-146a-5p生物发生,其耗尽会降低miR-146a-5p水平.
- 在OSCC中,miR-146a-5p充当了致癌性miRNA.
- SMAD4是miR-146a-5p的直接目标,其表达影响OSCC的瘤特征.
- METTL3影响SMAD4调节的基因,这表明它参与了TGF-β信号传递.
结论:
- 一种瘤基因METTL3通过OSCC中的miR-146a-5p调节瘤抑制剂SMAD4.
- 在OSCC.中确定了一个新的监管轴 (METTL3/miR-146a-5p/SMAD4).
- 这个轴对口腔状细胞癌治疗具有潜在的治疗意义.
相关概念视频
Metastasis
5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Abnormal Proliferation
4.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.3K
MicroRNAs
21.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.0K
Induced Pluripotent Stem Cells
3.8K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.8K

